Slow diffusion of lactose out of galectin-3 crystals monitored by X-ray crystallography: possible implications for ligand-exchange protocols

被引:55
作者
Collins, Patrick M.
Hidari, Kazuya I. P. J.
Blanchard, Helen
机构
[1] Griffith Univ, Inst Glycom, Gold Coast, Qld 9726, Australia
[2] Univ Shizuoka, Dept Biochem, Sch Pharmaceut Sci, Suruga Ku, Shizuoka 4228526, Japan
来源
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY | 2007年 / 63卷
关键词
D O I
10.1107/S090744490605270X
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Galectin-3 is a multifunctional carbohydrate-binding protein that has roles in cancer progression. In addition to carbohydrate-dependent extracellular functions, galectin-3 participates in carbohydrate-independent intracellular signalling pathways, including apoptosis, via protein-protein interactions, some of which engage the carbohydrate-binding groove. When ligands bind within this site, conformational rearrangements are induced and information on unliganded galectin-3 is therefore valuable for structure-based drug design. Removal of cocrystallized lactose from the human galectin-3 carbohydrate-recognition domain was achieved via crystal soaking, but took weeks despite low affinity. Pre-soaking to remove lactose enabled the subsequent binding of cryoprotectant glycerol, whereas when the lactose was not removed a priori the glycerol could not displace it in the short cryosoaking time frame. This slow diffusion of lactose out of the crystals contrasts with the entrance of glycerol, which takes place within minutes. The importance of the removal of incumbent ligands prior to attempts to introduce alternative ligands is indicated, even for proteins exhibiting low affinity for ligands, and has significance for ligand exchange in structure-based drug design.
引用
收藏
页码:415 / 419
页数:5
相关论文
共 32 条
[1]   THE CCP4 SUITE - PROGRAMS FOR PROTEIN CRYSTALLOGRAPHY [J].
BAILEY, S .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1994, 50 :760-763
[2]  
BARONDES SH, 1994, J BIOL CHEM, V269, P20807
[3]   Crystallization to obtain protein-ligand complexes for structure-aided drug design [J].
Danley, Dennis E. .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 2006, 62 :569-575
[4]   Coot:: model-building tools for molecular graphics [J].
Emsley, P ;
Cowtan, K .
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2004, 60 :2126-2132
[5]   MECHANISM OF INHIBITION OF HIV-1 REVERSE-TRANSCRIPTASE BY NONNUCLEOSIDE INHIBITORS [J].
ESNOUF, R ;
REN, JS ;
ROSS, C ;
JONES, Y ;
STAMMERS, D ;
STUART, D .
NATURE STRUCTURAL BIOLOGY, 1995, 2 (04) :303-308
[6]  
EVANS PR, 1993, P CCP4 STUD WEEK DAT, P114
[7]  
GALLOP PM, 1957, J BIOL CHEM, V227, P891
[8]   Simulation of diffusion time of small molecules in protein crystals [J].
Geremia, S ;
Campagnolo, M ;
Demitri, N ;
Johnson, LN .
STRUCTURE, 2006, 14 (03) :393-400
[9]   Oligosaccharide specificity of galectins: a search by frontal affinity chromatography [J].
Hirabayashi, J ;
Hashidate, T ;
Arata, Y ;
Nishi, N ;
Nakamura, T ;
Hirashima, M ;
Urashima, T ;
Oka, T ;
Futai, M ;
Muller, WEG ;
Yagi, F ;
Kasai, K .
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2002, 1572 (2-3) :232-254
[10]   Automated protein crystal structure determination using ELVES [J].
Holton, J ;
Alber, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (06) :1537-1542